Our findings showing up-regulation of RHOA/RAC/PAK signalling in Eμ-Myc/RelAT505A lymphomas, suggests that this pathway may function as a potential mechanism of CHK1i resistance bypass signalling. The gene discussed is MYC; the disease is lymphoma.